Aziz A Chentoufi

5PUBLICATIONS
14CO-AUTHORS
Disease surveillanceGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Infectious diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2025
Dysfunctional Senescent Herpes Simplex Virus-Specific CD57+CD8+ T Cells Are Associated with Symptomatic Recurrent Ocular Herpes in Humans.

Aziz A Chentoufi, Arif A Khan, Ruchi Srivastava

|Apr 10, 2025
A tissue-targeted prime/pull/keep therapeutic herpes simplex virus vaccine protects against recurrent ocular herpes infection and disease in HLA-A*0201 transgenic rabbits.

Aziz A Chentoufi, Swayam Prakash, Hawa Vahed

|Sep 28, 2023
CD4+ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword.

Kamal El Bissati, Paulette A Krishack, Ying Zhou

|Apr 29, 2021
Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.

Swayam Prakash, Ruchi Srivastava, Pierre-Gregoire Coulon

|May 26, 2017
Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Arif A Khan, Ruchi Srivastava, Aziz A Chentoufi

Pageof 1

Frequent Collaborators

2 joint publications

Alessandro Sette

2 joint publications

Lbachir BenMohamed

1 joint publications

Arif A Khan

1 joint publications

Sravya Chilukuri